Does fever control matter in critically ill patients? The HEAT randomized controlled trial (RCT) investigated the use of acetaminophen (paracetamol) to reduce fever in critically ill patients with suspected infection. The study compared the effects of acetaminophen administration to a placebo in these patients, specifically looking at outcomes including mortality, organ dysfunction, and temperature regulation. The results showed no significant difference in mortality or major clinical outcomes between the acetaminophen and placebo groups, despite a reduction in body temperature in the acetaminophen group. The study concluded that fever reduction with acetaminophen in critically ill patients with suspected infection does not confer a survival benefit and is not associated with improvements in major clinical outcomes.